Literature DB >> 11068571

The limitations of evidence from randomized trials.

S Magder1.   

Abstract

Mesh：

Year:  2000        PMID： 11068571      PMCID： PMC80548     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask.

Authors:  A D Bersten; A W Holt; A E Vedig; G A Skowronski; C J Baggoley
Journal:  N Engl J Med       Date:  1991-12-26       Impact factor: 91.245

2.  Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  L Brochard; J Mancebo; M Wysocki; F Lofaso; G Conti; A Rauss; G Simonneau; S Benito; A Gasparetto; F Lemaire
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

3.  Noninvasive positive-pressure ventilation: a utilization review of use in a teaching hospital.

Authors:  T Sinuff; D Cook; J Randall; C Allen
Journal:  CMAJ       Date:  2000-10-17       Impact factor: 8.262

4.  Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy.

Authors:  M Wysocki; L Tric; M A Wolff; H Millet; B Herman
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

5.  A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure.

Authors:  M Antonelli; G Conti; M Rocco; M Bufi; R A De Blasi; G Vivino; A Gasparetto; G U Meduri
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

6.  Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.

Authors:  J Bott; M P Carroll; J H Conway; S E Keilty; E M Ward; A M Brown; E A Paul; M W Elliott; R C Godfrey; J A Wedzicha; J Moxham
Journal:  Lancet       Date:  1993-06-19       Impact factor: 79.321
  6 in total
  1 in total

1.  Non-invasive ventilation as a first-line treatment for acute respiratory failure: "real life" experience in the emergency department.

Authors:  C Antro; F Merico; R Urbino; V Gai
Journal:  Emerg Med J       Date:  2005-11       Impact factor: 2.740
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.